10193- BT-8 4 CASES OF SECONDARY CANCER AFTER TREATMENT FOR PEDIATRIC MEDULLOBLASTOMA
Naoyuki Ohe, Takeaki Tamura, Toshinobu Kumagai, Kenji Shoda, Noriyuki Nakayama, Tsuyoshi Izumo · 2024
Read 10193- BT-8 4 CASES OF SECONDARY CANCER AFTER TREATMENT FOR PEDIATRIC MEDULLOBLASTOMA by Naoyuki Ohe, Takeaki Tamura, Toshinobu Kumagai, Kenji Shoda, Noriyuki Nakayama, Tsuyoshi Izumo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605654.txt.
Description
Ohe and colleagues (2024) report four cases of second cancers that arose after treatment for childhood medulloblastoma, a brain tumor. As treatment has improved, more children survive long term, and new tumors years later have become a real problem. Of 26 children treated at their department, four developed second neoplasms, 6 to 33 years after the first treatment, at ages 17 to 48.
The new tumors were two glioblastomas in the cerebellum, one diffuse midline glioma, and one case of multiple meningiomas. The two glioblastoma patients died within about a year despite treatment. The meningioma patient had surgery and keeps an independent life. Among the four patients who survived over 30 years, two developed second cancers. The authors note that risk grows with time past ten years, and that radiation at a young age is a known factor, though dose, chemotherapy, and inherited risk all need weighing together.
Catalog record
| CREATOR | Naoyuki Ohe, Takeaki Tamura, Toshinobu Kumagai, Kenji Shoda, Noriyuki Nakayama, Tsuyoshi Izumo |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |